Literature DB >> 8982418

A case-control study of hidradenitis suppurativa in an STD population.

G B Jemec1, M Heidenheim, N H Nielsen.   

Abstract

The prevalence of hidradenitis suppurativa has been found to be higher among patients attending an STD clinic than in an unselected general population sample. The aetiology of hidradenitis in unknown, but an association with chlamydial infections has been suggested for perineal lesions. Our aim was to describe the history of STD, STD risk factors and possible current STD in patients with hidradenitis. A case-control study comparing patients with hidradenitis (20) and controls (60) was therefore made in patients attending an STD clinic. Genital HPV infection was found to be more common in patients with hidradenitis (p = 0.036), but no differences were seen in the history of STD, STD risk behaviour or other current STD between the two groups studied. HPV infection appears to be the only STD which is more common in hidradenitis patients, but the biological significance of this finding is not clear. It is speculated that common predisposing factors may be responsible. We were unable to support the previously postulated association between Chlamydia trachomatis infection and hidradenitis.

Entities:  

Mesh:

Year:  1996        PMID: 8982418     DOI: 10.2340/0001555576482483

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

Review 1.  Hidradenitis suppurativa in children and adolescents: a review of treatment options.

Authors:  Peter Riis Mikkelsen; Gregor B E Jemec
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

Review 2.  The role of negative pressure wound therapy in the management of hidradenitis suppurativa: a case report and literature review.

Authors:  Raphael Parrado; Manuel Cadena; Arturo Vergara; Diana Cadena; Juan G Chalela
Journal:  Int Wound J       Date:  2015-12-13       Impact factor: 3.315

Review 3.  IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.

Authors:  J M Fletcher; B Moran; A Petrasca; C M Smith
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.